Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 65, Number 7, October 11, 2005
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyman, S. L.
Right arrow Articles by North, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyman, S. L.
Right arrow Articles by North, K. N.
Related Collections
Right arrow All Neuropsychology/Behavior
Right arrow All Pediatric
Right arrow Mental retardation
Right arrow Neurofibromatosis
Right arrowRelated Article
NEUROLOGY 2005;65:1037-1044
© 2005 American Academy of Neurology

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1

Shelley L. Hyman, PhD, Arthur Shores, PhD and Kathryn N. North, MD

From the Neurogenetics Research Unit (Drs. Hyman and North), Children's Hospital at Westmead, Discipline of Paediatrics and Child Health (Drs. Hyman and North), Faculty of Medicine, University of Sydney, and Department of Psychology (Dr. Shores), Macquarie University, Sydney, New South Wales, Australia.

Address correspondence and reprint requests to Dr North, Children's Hospital at Westmead, Clinical Sciences Building, Locked Bag 4001, Westmead, NSW 2145, Australia; e-mail: kathryn{at}chw.edu.au

Objective: To assess the frequency and severity of specific cognitive deficits in children with neurofibromatosis type 1 (NF1) in a large unbiased cohort.

Methods: Extensive cognitive assessments were performed in 81 children with NF1 ages 8 to 16 years and their performance was compared with that of 49 unaffected sibling controls.

Results: Eighty-one percent of the children with NF1 had moderate to severe impairment in one or more areas of cognitive functioning. Although 51% of children with NF1 performed poorly on tasks of reading, spelling, and mathematics, specific learning disabilities (as defined by IQ–achievement discrepancies) were present in only 20% of the children. Sustained attention difficulties were present in 63% of children with NF1, with 38% of children with NF1 fulfilling the diagnostic criteria for attention deficit–hyperactivity disorder. The NF1 neuropsychological profile is characterized by deficits in perceptual skills (visuospatial and visuoperceptual), executive functioning (planning and abstract concept formation), and attention (sustained and switching). Interestingly, both verbal and visual memory was unaffected in NF1 children, and their memory skills were in general stronger than their level of general intellectual function. Although both expressive and receptive language skills were significantly impaired in NF1 children, they appeared to be relatively better preserved than visuospatial abilities once IQ is taken into account.

Conclusion: There is an extremely high frequency of cognitive problems in children with neurofibromatosis type 1, making cognitive dysfunction the most common complication to affect quality of life in these children.


Supported by the Department of Defense Neurofibromatosis Research Program, managed by the U.S. Army Medical Research and Materiel Command (USAMRMC: award no. DAMD17-00-1-0534), and the National Neurofibromatosis Foundation, USA.

Disclosure: The authors report no conflicts of interest.

Received February 24, 2005. Accepted in final form June 14, 2005.


Related Article

October 11 Highlights
Neurology 2005 65: 976-977. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Med. Genet.Home page
H Kehrer-Sawatzki and D N Cooper
Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
J. Med. Genet., October 1, 2008; 45(10): 622 - 631.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
L. C. Krab, F. K. Aarsen, A. de Goede-Bolder, C. E. Catsman-Berrevoets, W. F. Arts, H. A. Moll, and Y. Elgersma
Impact of Neurofibromatosis Type 1 on School Performance
J Child Neurol, September 1, 2008; 23(9): 1002 - 1010.
[Abstract] [PDF]


Home page
J Pediatr PsycholHome page
J. Reiter-Purtill, E. K. Schorry, A. M. Lovell, K. Vannatta, C. A. Gerhardt, and R. B. Noll
Parental Distress, Family Functioning, and Social Support in Families with and without a Child with Neurofibromatosis 1
J. Pediatr. Psychol., May 1, 2008; 33(4): 422 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. L Hyman, D. S Gill, E. A. Shores, A. Steinberg, and K. N North
T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1088 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J Atten DisordHome page
F. X. Coude, C. Mignot, S. Lyonnet, and A. Munnich
Early Grade Repetition and Inattention Associated With Neurofibromatosis Type 1
J Atten Disord, September 1, 2007; 11(2): 101 - 105.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.